Trial Profile
Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer: A Randomized, Controlled, Prospective, Observational Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Toremifene (Primary) ; Tamoxifen
- Indications Early breast cancer
- Focus Adverse reactions
- Acronyms TTOS
- 24 Apr 2019 Planned number of patients changed from 126 to 104.
- 05 Apr 2019 Status changed from active, no longer recruiting to completed.
- 20 Sep 2017 Planned End Date changed from 1 Jun 2018 to 1 Aug 2018.